International: The vaccine, called Orthopoxvac, was developed by the Vektor laboratory in Siberia and registered by Russia's health ministry in 2022 following clinical trials, which, according to ...

Democratic Republic of Congo has been unable to launch an mpox vaccination campaign in the capital Kinshasa due to a shortage ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...

The key faultline in the negotiations lies between Western nations with major pharmaceutical industry sectors, and poorer ...

British health officials say they have identified four cases of the new, more infectious version of mpox that first emerged ...